Verona Pharma Reports Third Quarter 2024 Financial Results And Provides Corporate Update

(MENAFN - GlobeNewsWire - Nasdaq) OhtuvayreTM (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3 Through October more than 2,200 unique prescribers and ...Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute